Search results for "Intestine"

showing 10 items of 390 documents

The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase

2005

Abstract Background The involvement of Heat Shock Proteins (HSP) in cancer development and progression is a widely debated topic. The objective of the present study was to evaluate the presence and expression of HSP60 and HSP10 in a series of large bowel carcinomas and locoregional lymph nodes with and without metastases. Methods 82 Astler and Coller's stage C2 colorectal cancers, of which 48 well-differentiated and 34 poorly-differentiated, were selected along with 661 lymph nodes, including 372 with metastases and 289 with reactive hyperplasia only, from the same tumours. Primitive tumours and both metastatic and reactive lymph nodes were studied; specifically, three different compartment…

Cancer ResearchPathologymedicine.medical_specialtyTime FactorsColonColorectal cancerBlotting Westernlcsh:RC254-282Surgical oncologyIntestinal NeoplasmsBiomarkers TumorChaperonin 10GeneticsmedicineCarcinomaHumansIntestine LargeNeoplasm MetastasisStage (cooking)Lymph nodeInflammationAnalysis of VarianceHyperplasiabusiness.industryCarcinomaCell DifferentiationChaperonin 60Hyperplasialcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseImmunohistochemistryGene Expression Regulation Neoplasticmedicine.anatomical_structureOncologyLymphatic MetastasisDisease ProgressionImmunohistochemistryhspLymph NodesLymphbusinessResearch ArticleBMC Cancer
researchProduct

Intestinal epithelial HuR modulates distinct pathways of proliferation and apoptosis and attenuates small intestinal and colonic tumor development.

2014

Abstract HuR is a ubiquitous nucleocytoplasmic RNA-binding protein that exerts pleiotropic effects on cell growth and tumorigenesis. In this study, we explored the impact of conditional, tissue-specific genetic deletion of HuR on intestinal growth and tumorigenesis in mice. Mice lacking intestinal expression of HuR (Hur IKO mice) displayed reduced levels of cell proliferation in the small intestine and increased sensitivity to doxorubicin-induced acute intestinal injury, as evidenced by decreased villus height and a compensatory shift in proliferating cells. In the context of Apcmin/+ mice, a transgenic model of intestinal tumorigenesis, intestinal deletion of the HuR gene caused a three-fo…

Cancer ResearchPost-translational regulationRNA-binding proteinContext (language use)ApoptosisCell Growth ProcessesBiologymedicine.disease_causeArticleAU-rich RNAMiceGene expressionIntestinal NeoplasmsmedicineAnimalsmRNA stabilityIntestinal MucosaMice KnockoutCell growthMolecular biologyPhenotypeProtein-RNA interactionSmall intestineDisease Models Animalmedicine.anatomical_structureOncologyELAV ProteinsApoptosisColonic NeoplasmsCancer researchCarcinogenesis
researchProduct

Mammalian intestinal alkaline phosphatase acts as highly active exopolyphosphatase.

2001

Recent results revealed that inorganic polyphosphates (polyP), being energy-rich linear polymers of orthophosphate residues known from bacteria and yeast, also exist in higher eukaryotes. However, the enzymatic basis of their metabolism especially in mammalian cells is still uncertain. Here we demonstrate for the first time that alkaline phosphatase from calf intestine (CIAP) is able to cleave polyP molecules up to a chain length of about 800. The enzyme acts as an exopolyphosphatase degrading polyP in a processive manner. The pH optimum is in the alkaline range. Divalent cations are not required for catalytic activity but inhibit the degradation of polyP. The rate of hydrolysis of short-ch…

Cations DivalentBiophysicsBiologymedicine.disease_causeBiochemistryDivalentSubstrate SpecificityNitrophenolschemistry.chemical_compoundOrganophosphorus CompoundsStructural BiologyNickelPolyphosphatesmedicineAnimalsMagnesiumneoplasmsMolecular BiologyEscherichia coliEdetic AcidExopolyphosphatasechemistry.chemical_classificationPolyphosphateSubstrate (chemistry)MetabolismCobaltHydrogen-Ion ConcentrationAlkaline PhosphataseMolecular biologydigestive system diseasesAcid Anhydride HydrolasesIntestinesKineticsEnzymechemistryBiochemistryAlkaline phosphataseCattleBiochimica et biophysica acta
researchProduct

Optimization of the Ussing chamber setup with excised rat intestinal segments for dissolution/permeation experiments of poorly soluble drugs.

2016

AbstractContext: Prediction of the in vivo absorption of poorly soluble drugs may require simultaneous dissolution/permeation experiments. In vivo predictive media have been modified for permeation experiments with Caco-2 cells, but not for excised rat intestinal segments.Objective: The present study aimed at improving the setup of dissolution/permeation experiments with excised rat intestinal segments by assessing suitable donor and receiver media.Methods: The regional compatibility of rat intestine in Ussing chambers with modified Fasted and Fed State Simulated Intestinal Fluids (Fa/FeSSIFmod) as donor media was evaluated via several parameters that reflect the viability of the excised in…

Cell Membrane PermeabilityPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacyBile Acids and Salts03 medical and health sciences0302 clinical medicineIn vivoDrug DiscoveryAnimalsHumansDissolutionPharmacologyRat intestineChromatographyUssing chamberChemistryOrganic ChemistryIn vivo absorptionPermeation021001 nanoscience & nanotechnologyRatsIntestinesJejunumSolubilityCaco-2 Cells0210 nano-technologyFederal stateDrug development and industrial pharmacy
researchProduct

Toward Biopredictive Dissolution for Enteric Coated Dosage Forms

2016

The aim of this work was to develop a phosphate buffer based dissolution method for enteric-coated formulations with improved biopredictivity for fasted conditions. Two commercially available enteric-coated aspirin products were used as model formulations (Aspirin Protect 300 mg, and Walgreens Aspirin 325 mg). The disintegration performance of these products in a physiological 8 mM pH 6.5 bicarbonate buffer (representing the conditions in the proximal small intestine) was used as a standard to optimize the employed phosphate buffer molarity. To account for the fact that a pH and buffer molarity gradient exists along the small intestine, the introduction of such a gradient was proposed for p…

Chemistry PharmaceuticalCmaxBiological AvailabilityPharmaceutical Science02 engineering and technologyBuffers030226 pharmacology & pharmacyDosage form03 medical and health sciencesFirst pass effect0302 clinical medicineIVIVCCoated Materials BiocompatibleIntestine SmallDrug DiscoverymedicineHumansSolubilityDissolutionDosage FormsChromatographyAspirinGastric emptyingChemistryHydrogen-Ion Concentration021001 nanoscience & nanotechnologyEnteric coatingBicarbonatesDrug LiberationKineticsGastric EmptyingSolubilityArea Under CurveMolecular Medicine0210 nano-technologymedicine.drugMolecular Pharmaceutics
researchProduct

�ber die Hemmung der Atp-Spaltung in der D�nndarmschleimhaut durch Kupfer

1952

Chemistrychemistry.chemical_elementGeneral MedicineDecompositionMolecular medicineCopperSmall intestinechemistry.chemical_compoundmedicine.anatomical_structureBiochemistryDrug DiscoverymedicineMolecular MedicineAdenosine triphosphateGenetics (clinical)AdenylpyrophosphateKlinische Wochenschrift
researchProduct

Gliadin, zonulin and gut permeabilità: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.

2006

Objective. Little is known about the interaction of gliadin with intestinal epithelial cells and the mechanism(s) through which gliadin crosses the intestinal epithelial barrier. We investigated whether gliadin has any immediate effect on zonulin release and signaling. Material and methods. Both ex vivo human small intestines and intestinal cell monolayers were exposed to gliadin, and zonulin release and changes in paracellular permeability were monitored in the presence and absence of zonulin antagonism. Zonulin binding, cytoskeletal rearrangement, and zonula occludens-1 (ZO-1) redistribution were evaluated by immunofluorescence microscopy. Tight junction occludin and ZO-1 gene expression …

Cholera ToxinGene ExpressionEnzyme-Linked Immunosorbent AssayOccludindigestive systemCoeliac diseaseGliadinPermeabilityTight JunctionsIntestinal mucosaOccludinIntestine SmallmedicineAnimalsHumansIntestinal MucosaProtein PrecursorsCells CulturedIntestinal permeabilitybiologyTight junctionHaptoglobinsGastroenterologynutritional and metabolic diseasesZonulinMembrane ProteinsEpithelial Cellsmedicine.diseasePhosphoproteinsMolecular biologydigestive system diseasesRatsCeliac DiseaseMicroscopy FluorescenceParacellular transportImmunologybiology.proteinZonula Occludens-1 ProteinGliadin
researchProduct

2020

In this study, the potential for correlation between disintegration and dissolution performance of enteric-coated (EC) dosage forms was investigated. Different enteric hard shell capsule formulations containing caffeine as model drug were tested for disintegration (in a compendial disintegration tester) and for dissolution in both USP type I (basket) and type II (paddle) apparatuses using different media. Overall, good correlations were obtained. This was observed for both the basket and the paddle apparatus, indicating that the use of disintegration testing as a surrogate for dissolution testing (allowed by International Conference on Harmonization (ICH) for immediate release dosage forms …

ChromatographyChemistryPharmaceutical ScienceCapsule02 engineering and technology021001 nanoscience & nanotechnologyPositive correlation030226 pharmacology & pharmacySmall intestineDosage formIn vitro03 medical and health sciences0302 clinical medicinemedicine.anatomical_structuremedicineDissolution testingImmediate release0210 nano-technologyDissolutionPharmaceutics
researchProduct

New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy

2020

[EN] Colonic Drug Delivery Systems (CDDS) are especially advantageous for local treatment of inflammatory bowel diseases (IBD). Site-targeted drug release allows to obtain a high drug concentration in injured tissues and less systemic adverse effects, as consequence of less/null drug absorption in small intestine. This review focused on the reported contributions in the last four years to improve the effectiveness of treatments of inflammatory bowel diseases. The work concludes that there has been an increase in the development of CDDS in which pH, specific enzymes, reactive oxygen species (ROS), or a combination of all of these triggers the release. These delivery systems demonstrated a th…

ColonAdministration OralReview02 engineering and technologyDiseaseIntestinal permeabilityInflammatory bowel diseasesPharmacology030226 pharmacology & pharmacyInflammatory bowel diseaseCatalysislcsh:ChemistryInorganic Chemistry03 medical and health sciencesDrug Delivery SystemsQUIMICA ORGANICA0302 clinical medicineIn vivoQUIMICA ANALITICAmedicineAnimalsHumansPhysical and Theoretical ChemistryMesalamineAdverse effectlcsh:QH301-705.5Molecular BiologySpectroscopyIntestinal permeabilitybusiness.industryQUIMICA INORGANICAOrganic ChemistryInflammatory Bowel DiseasesGeneral MedicineColitis021001 nanoscience & nanotechnologymedicine.diseaseSmall intestineComputer Science ApplicationsAminosalicylic AcidsDrug Liberationmedicine.anatomical_structurelcsh:Biology (General)lcsh:QD1-999Drug deliveryDrug delivery0210 nano-technologybusinessInternational Journal of Molecular Sciences
researchProduct

Epithelial NEMO links innate immunity to chronic intestinal inflammation

2007

Deregulation of intestinal immune responses seems to have a principal function in the pathogenesis of inflammatory bowel disease(1-4). The gut epithelium is critically involved in the maintenance of intestinal immune homeostasis-acting as a physical barrier separating luminal bacteria and immune cells, and also expressing antimicrobial peptides(3,5,6). However, the molecular mechanisms that control this function of gut epithelial cells are poorly understood. Here we show that the transcription factor NF kappa B, a master regulator of pro-inflammatory responses(7,8), functions in gut epithelial cells to control epithelial integrity and the interaction between the mucosal immune system and gu…

ColonAntimicrobial peptidesApoptosisBiologyPathogenesisInterleukin 22MiceImmune systemAnimalsHomeostasisMultidisciplinaryInnate immune systemNF-kappa BEpithelial CellsColitisImmunity InnateI-kappa B KinaseGut EpitheliumCell biologyIntestinesReceptors Tumor Necrosis Factor Type IChronic DiseaseMyeloid Differentiation Factor 88Tumor Necrosis FactorsImmunologyChronic inflammatory responseTumor necrosis factor alphaSignal TransductionNature
researchProduct